 |
 |
Dr. Moussa, I understand from one of the Parkinson's email groups that Dr. Pagan is still seeking funding for a larger trial to evaluate the potential benefit of Nilotinib to persons with Parkinson's Disease. If this is so, perhaps you can reach-out to the Parkinson's community for additional funds and potential leads for additional funding. We in the community are anxious and impatient for a new and hopefully more beneficial treatment than those currently available. The reported potential benefit of Nilotinib to Parkinson's patients is quite encouraging. Respectfully, Tony Adler, Caregiver ---------------------------------------------------------------------- To sign-off Parkinsn send a message to: mailto:[log in to unmask] In the body of the message put: signoff parkinsn